BioBuzz Regional Recap | Greater Philadelphia | March 10, 2025

Mar 7, 2025 - 07:30
Mar 11, 2025 - 07:34
BioBuzz Regional Recap | Greater Philadelphia | March 10, 2025

After another busy week, we’re seeing a mix of uncertainty and opportunity. With the current administration’s policies and tariffs creating waves, businesses are navigating a shifting landscape. Meanwhile, exciting job openings are steadily emerging across the region, offering fresh career opportunities. Local Philly companies are also making headlines with strong financial and commercial results, signaling growth and stability. 

As always, we’ve compiled the top stories of the week for you down below!

Bryan Kennedy + Owen Buzy

BioBuzz Networks | Greater Philadelphia

philadelphia@biobuzz.io

FINANCIAL

  • Azzur: Reaches Agreement to Sell Consulting Business for $56 Million to ELIQUENT Life Sciences More

  • Ocugen: Business Update With Fourth Quarter and Full Year 2024 Financial Results More
  • Tevogen Bio: To Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations  More

  • UroGen Pharma: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More

CLINICAL & COMMERCIAL

  • The Wistar Institute: Discovers a Promising Target in Brain Cancer More

  • Traws Pharma: Positive Results From an Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil More

  • Ocugen: Positive Opinion of EMA’s Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease More

  • Protega Pharmaceuticals: Collaborates With Wellgistics Health to Support Pharmacist Education and Increase Patient Access to the First and Only FDA-Approved Abuse-Deterrent Immediate-Release Opioid, Roxybond More

  • TransCelerate BioPharma: Publishes Resources to Accelerate Industry Adoption of Newly-Released ICH E6(R3) Guidelines More

  • Windtree: Istaroxime Notice of Allowance From the U.S. Patent and Trademark Office for Acute Heart Failure More

  • NIIMBL: RFA for Optimizing Long-read Next-gen Sequencing Capabilities More

  • Children's Hospital of Philadelphia: Researchers: Use a "Trojan Horse" Approach to Develop New Antimalarial Drugs More

  • Integral Molecular: Out-licensed Bispecific Antibody Enters Clinical Trial for Treating Solid Tumors More

  • Medicus Pharma: Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) More

  • Virpax: Looking to Use MET to Develop Intranasal COVID Vaccine More

  • Synnovation Therapeutics: First Patient Dosed in Phase I Trial with SNV4818, a Potential Best-In-Class Pan-Mutant-Selective PI3Kα Inhibitor for the Treatment of Solid Tumors More

WORKFORCE

  • SparingVision: appoints Anjeza Gjino as Chief Financial Officer More

  • Certara: Appoints Dr. Adrian McKemey as President of Drug Development Solutions More

  • Louis Kassa: Named to Philadelphia Business Journal’s Power 100 More

  • The Wistar Institute: Recruitment of First Caspar Wistar Fellow to Join HIV Cure and Viral Diseases Center More

JOBS

Ocugen (Malvern, PA)

Website | LinkedIn 

Ocugen, a fully integrated, patient-centric biotech company, is hiring for many roles including Head of Clinical Development and Vice President of Manufacturing & Supply.

Here are some other innovative companies in the region that are hiring:

  • Harmony Biosciences (Plymouth Meeting, PA) - A leading pharma company dedicated to innovative therapies for patients with rare neurological diseases. Check out jobs here>

    • Director, Medical Writing

    • Senior Director, Clinical Pharmacology

    • Senior Director, Business Development

  • Context Therapeutics (Philadelphia, PA) - A biopharma company advancing T cell engaging bispecific antibodies for solid tumors. Check out jobs here>

    • Head of Regulatory

    • Senior Director/VP, Data management

    • Director/Senior Director, Project Management

  • Cabaletta Bio (Philadelphia, PA) - A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies here>

    • Director, Clinical Program Management

    • Director, Clinical Scientist

    • Senior Director, CMC Regulatory Affairs

  • VintaBio (Philadelphia, PA) - Viral Vector Manufacturing. Check out jobs here>

    • Head of Analytical Development & Quality Control

    • Quality Assurance Document Control Training Manager

    • Office Manager

  • Century Therapeutics (Philadelphia, PA) - Century Therapeutics is an innovative biotechnology company that is building an industry leading allogeneic iPSC-derived cell therapy platform. Check out jobs here>

    • Scientific Director, Upstream Process

    • Senior Director, Clinical Development

    • CMMS Specialist

BUZZIN' EVENT

Find Out More on Our Next Event

BioInnovation Series Event Series Stop #2: Philadelphia's Push: Breaking Barriers in Rare Disease Research

Building off our successful BioInnovation Series launch event in February, we’re continuing the momentum with our next session—this time focused on Rare Disease Innovation. Philadelphia is home to groundbreaking advancements in rare disease research and therapeutic development, but how do we ensure these innovations lead to lasting impact, growth, and better patient outcomes?

Find Out More>
BioBuzz Media BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.